14th International Conference on the Chemistry of Antibiotics and other Bioactive Compounds, 13-16 October 2015, Texas, USA


Craig W. Lindsley, Vanderbilt University, USA

Craig W. LindsleyCraig W. Lindsley, Ph.D. is the Co-Director and Director of Medicinal Chemistry for the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) and running for the role of Academic Councilor for the MEDI division.  Craig graduated in 1992 from California State University, Chico with a B.S. in Chemistry, received his Ph.D. degree in Chemistry from the University of California, Santa Barbara (Lipshutz), in 1996, and pursued postdoctoral studies at Harvard University (Shair). In 2001, Craig accepted a position at Merck & Co where he pioneered, in positions of increasing responsibility, the development of allosteric ligands for Akt, mGlu5 and M1, providing critical proof-of-concept compounds that validated the mechanism of allosteric modulation and clinical candidates.  In 2006, Craig accepted an Associate Professor position in Pharmacology and Chemistry at Vanderbilt University, and promoted to Full Professor in 2009.  In that same year, Craig became the founding Editor-in-Chief of ACS Chemical Neuroscience and was also awarded the ASPET-Astellas Award for Translational Pharmacology.  In 2013, Craig was awarded the Portoghese Lectureship from the ACS MEDI division and the Journal of Medicinal Chemistry for impact in the field of medicinal chemistry, and in 2014, received the John J. Abel Award in Pharmacology from ASPET. Craig holds over 60 issued US patents and has published over 300 manuscripts and another 140 published patent applications.

« Go Back

Organised by




Supporting Journal

Bioorganic & Medicinal Chemistry Letters